Hospice M&A Expected to Stay Strong in 2022

Despite prevailing COVID-19 headwinds, the hospice and home health mergers and acquisitions market shows no signs of slowing. Labor shortages plaguing the industry may be spurring additional activity as the dwindling workforce is limiting some providers’ ability to grow organically. A number of the larger strategic buyers — LHC Group (NASDAQ: LHCG), Amedisys (NASDAQ: AMED), […]

Ten States Sue Biden, CMS to Stop COVID Vaccine Mandate

Ten U.S. states have filed a lawsuit against members of the Biden administration asking the U.S. District Court of Eastern Missouri to strike down the recently announced COVID-19 vaccine mandate from the U.S. Centers for Medicare & Medicaid Services (CMS), arguing that the rule would exacerbate workforce shortages and represents overreach of federal authority. Plaintiffs […]

Amedisys CEO: Shrinking Hospice Market to Bounce Back by 2023

COVID-19 headwinds slowed hospice growth during 2020 and 2021. This will likely trend into 2022, but signs of recovery are starting to show, according to Paul Kusserow, CEO of Amedisys (NASDAQ: AMED). During the past two years hospices have contended with worsening staff shortages, rising supply costs, increased paid leave and employee quarantines due to […]

Pennant Group Slowing Acquisitions Through End of Year

The Pennant Group (NASDAQ: PNTG) will likely slow down its acquisition activity during the remainder of the year and early 2022 as they work to recover from pandemic headwinds that bruised the hospice, home health and senior housing provider during the third quarter. Pennant has been aggressive on acquisitions during the past two years, including […]

VITAS Makes Hospice Opioid Conversion App Available to All Providers

VITAS Healthcare, a subsidiary of Chemed Corp. (NYSE: CHEM), has released a comprehensive opioid conversion tool for hospice providers, which the company says is the first of its kind. The tool is available to all health care prescribers at no cost via the VITAS mobile app.  VITAS released the feature in conjunction with National Hospice […]

CMMI’s Strategy Refresh: What Hospices Need to Know

The Center for Medicare & Medicaid Innovation (CMMI) in October announced a “strategy refresh” that would guide development of its future payment models. If executed effectively, the strategy could make a substantial difference in hospice and palliative care as well as the health care system at large, a trio of experts told Hospice News.  The […]

Future Leaders: Alexander Koshevatsky, CEO, Healthflex Hospice

The Future Leaders Awards program is brought to you in partnership with PointClickCare. The program is designed to recognize up-and-coming industry members who are shaping the next decade of senior housing, skilled nursing, home health and hospice care. To see this year’s future leaders, visit https://futureleaders.agingmedia.com/. Alexander Koshevatsky, CEO of Healthflex Hospice, has been named […]

Psychedelics Could Be New Frontier in End-of-Life Care

Psychedelic medicines may represent a new frontier for end-of-life care, as well as psychiatric treatment. While these substances — including LSD, MDMA, psilocybin and ketamine, among others — remain illegal, grass roots support for decriminalization or medical use is growing. Meanwhile, venture capitalists and other investors are spending billions to get on the ground floor […]

[UPDATED] CMS, OSHA Issue Vaccine Mandate for All Health Care Workers

The U.S. Centers for Medicare & Medicaid Services (CMS) and the U.S. Occupational Safety & Health Administration (OSHA) have issued emergency regulations requiring COVID-19 vaccination for eligible staff at health care organizations that participate in Medicare or Medicaid. Health care employers must implement a policy requiring staff to receive the first vaccine dose prior to […]

Amedisys CEO: Contessa Could Double Footprint, Expand Palliative Care

A forthcoming deal and new hospital system partnerships stands to potentially double Contessa’s footprint through the end of this year and into 2022. Contessa is a subsidiary of Amedisys (NASDAQ: AMED), which acquired the company in June for a total consideration of $250 million. In the midst of this expansion, the company has plans to […]